Better Prevention for Breast Cancer & Estrogen related Cancers
Date Posted: 09/07/2010
How can a simple urine test prevent breast cancer? Specific estrogen metabolites may initiate and promote hormone-related cancers. Research has shown that the proportion of estrogen that is metabolized via the 16-a-hydroxyestrone pathway is associated with breast cancer risk, as well as urinary 2:16 ratio which can be used as a biomarker for risk. One metabolite, 2-hydroxyestrone (2-OHE1), tends to inhibit cancer growth. Another, 16-a-hydroxyestrone (16-a-OHE1), actually encourages tumor development.
A woman’s “biochemical individuality” determines which of these metabolites predominates. Studies have shown that measuring the ratio of these two metabolites provides an important indication of risk for future development of estrogen-sensitive cancers. The studies also show that this risk can be modified. Why should I use the urine test for prevention? This preventative testing measures the ratio of these two critical estrogen metabolites, 2-OHE1 and 16-a-OHE1, from a single urine specimen. 2:16 ratios less than 2.0 may indicate long-term risk for breast, cervical, and other estrogen-sensitive cancers. Importantly, nutritional interventions have been shown to help raise these 2:16 ratios and decrease long-term risk. About 207,090 new cases of invasive breast cancer will occur among women in the United StateHow can a simple urine test prevent breast cancer?
Specific estrogen metabolites may initiate and promote hormone-related cancers. Research has shown that the proportion of estrogen that is metabolized via the 16-a-hydroxyestrone pathway is associated with breast cancer risk, as well as urinary 2:16 ratio which can be used as a biomarker for risk.
One metabolite, 2-hydroxyestrone (2-OHE1), tends to inhibit cancer growth. Another, 16-a-hydroxyestrone (16-a-OHE1), actually encourages tumor development. A woman’s “biochemical individuality” determines which of these metabolites predominates. Studies have shown that measuring the ratio of these two metabolites provides an important indication of risk for future development of estrogen-sensitive cancers. The studies also show that this risk can be modified.
Why should I use the urine test for prevention?
This preventative testing measures the ratio of these two critical estrogen metabolites, 2-OHE1 and 16-a-OHE1, from a single urine specimen. 2:16 ratios less than 2.0 may indicate long-term risk for breast, cervical, and other estrogen-sensitive cancers. Importantly, nutritional interventions have been shown to help raise these 2:16 ratios and decrease long-term risk.
About 207,090 new cases of invasive breast cancer will occur among women in the United States during 2010 And an estimated 39,840 women will die from breast cancer this year.
— Susan G. Komen Foundation, Statistics, 2010
Mammography, Changes and Risks:
New government-sponsored guidelines for mammograms now call for women to start getting their mammograms at age of 50, rather than at the previously recommended age of 40 years. and repeat the test every two years rather than yearly. The guidelines state that screening before the age of 50 should be an individual choice based on family history and general health. Like all medical interventions, mammograms have benefits and risks. Based on data analysis, which was thoroughly described in a series of articles published in the Nov. 17th 2009 issue of the Annals of Internal Medicine, the panel determined that getting screened for breast cancer early and often leads to False Alarms. By Glenn D Braunstein, M.D. Chairman of the Department of Medicine at Cedars-Sinai Medical Center
The Downfall of Mammography:
New York Times reported in August 2010,
Research studies demonstrate that the radiation emitted by mammography can actually increase the incidence of cancer. Two nuclear technologies, breast-specific gamma imaging (B.S.G.I.) and positron emission mammography (P.E.M.), expose “patients to a risk of radiation-induced cancer that is comparable to the risk from an entire lifetime of yearly mammograms starting at 40.”
Call Today for your simple urine test, Why Not? 720-581-1804
An estimated 39,840 women will die from breast cancer this year. — Susan G. Komen Foundation, Statistics, 2010 Mammography, Changes and Risks: New government-sponsored guidelines for mammograms now call for women to start getting their mammograms at age of 50, rather than at the previously recommended age of 40 years. and repeat the test every two years rather than yearly. The guidelines state that screening before the age of 50 should be an individual choice based on family history and general health.
Like all medical interventions, mammograms have benefits and risks. Based on data analysis, which was thoroughly described in a series of articles published in the Nov. 17th 2009 issue of the Annals of Internal Medicine, the panel determined that getting screened for breast cancer early and often leads to False Alarms. By Glenn D Braunstein, M.D. Chairman of the Department of Medicine at Cedars-Sinai Medical Center The Downfall of Mammography: New York Times reported in August 2010, Research studies demonstrate that the radiation emitted by mammography can actually increase the incidence of cancer. Two nuclear technologies, breast-specific gamma imaging (B.S.G.I.) and positron emission mammography (P.E.M.), expose “patients to a risk of radiation-induced cancer that is comparable to the risk from an entire lifetime of yearly mammograms starting at 40.”
Call Today for your simple urine test, Why Not? 720-581-1804